What is Bridgeway Diagnostics?
Bridgeway Diagnostics operates as a physician-owned entity, providing a comprehensive suite of screening and diagnostic imaging services. Their offerings include advanced technologies such as low-dose CT, X-Ray, Ultrasound, DXA, and digital mammography. Notably, Bridgeway Diagnostics is recognized as the first outpatient facility in its region to offer advanced radiation dose reduction CT and low-dose 3D breast tomography. The practice serves a broad patient demographic, accommodating individuals with metal implants and those requiring non-contrast MRI, thereby enhancing patient comfort and diagnostic accuracy. With established locations in Auburn, Columbus, and Phenix City, the company is dedicated to upholding the highest standards of patient care and facilitating early disease detection.
How much funding has Bridgeway Diagnostics raised?
Bridgeway Diagnostics has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
What's next for Bridgeway Diagnostics?
The substantial capital infusion, particularly the recent strategic investment, positions Bridgeway Diagnostics for significant expansion and technological advancement. As a late-stage company, this financing is likely to fuel initiatives aimed at enhancing operational efficiency, expanding service offerings, and potentially increasing market reach through new facilities or strategic partnerships. The focus on advanced imaging technologies suggests a commitment to staying at the forefront of medical diagnostics, which could involve further investment in cutting-edge equipment and specialized personnel to maintain a competitive edge in the evolving healthcare landscape.
See full Bridgeway Diagnostics company page
